Alpine Global Management, LLC Standard Biotools Inc. Transaction History

Alpine Global Management, LLC

  • $331 Million
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$1.65 - $2.92 $484,614 - $857,621
293,706 New
293,706 $519,000
Q3 2022

Nov 14, 2022
BUY
$1.1 - $2.06 $14,822 - $27,758
13,475 New
13,475 $15,000
Q1 2022

May 13, 2022
SELL
$2.8 - $3.96 $33,202 - $46,957
-11,858 Reduced 46.81%
13,475 $48,000
Q4 2021

Feb 14, 2022
BUY
$3.63 - $6.13 $91,958 - $155,291
25,333 New
25,333 $99,000
Q1 2021

May 13, 2021
SELL
$3.94 - $7.09 $82,669 - $148,762
-20,982 Closed
0 $0
Q4 2020

Feb 12, 2021
BUY
$5.45 - $8.65 $114,351 - $181,494
20,982 New
20,982 $126,000

Others Institutions Holding LAB

# of Institutions
142
Shares Held
279M
Call Options Held
27.2K
Put Options Held
34.1K
View Full List

About STANDARD BIOTOOLS INC.

LAB Quotes by TradingView
  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $144M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track Alpine Global Management, LLC Portfolio

Follow Alpine Global Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpine Global Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpine Global Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email